What anticonvulsant can be added to a regimen of Keppra (levetiracetam) and Lyrica (pregabalin) to help gain control over seizures?

Adding a Third Anticonvulsant to Keppra and Lyrica

Lacosamide is the optimal third anticonvulsant to add when seizures remain uncontrolled on levetiracetam (Keppra) and pregabalin (Lyrica). 1, 2

Rationale for Lacosamide Selection

Lacosamide provides mechanistic complementarity to your current regimen through its unique sodium channel slow-inactivation mechanism, which differs from levetiracetam's synaptic vesicle protein modulation. 1, 2 This combination strategy follows the principle that drugs with different mechanisms of action produce superior efficacy compared to agents with overlapping pharmacodynamics. 2

Evidence Supporting Lacosamide as Add-On Therapy

• Lacosamide is specifically recommended as an add-on treatment for patients whose seizure disorder is not controlled by monotherapy in neuro-oncology guidelines, which address refractory seizures. 1

• Levetiracetam combines favorably with sodium channel blockers like lacosamide in clinical studies, demonstrating effective seizure control without significant pharmacokinetic interactions. 2

• Lacosamide has minimal drug-drug interactions since it is not significantly protein-bound and does not induce or inhibit cytochrome P450 enzymes, making it safe to combine with levetiracetam. 3

Important Clarification About Pregabalin (Lyrica)

Pregabalin is not indicated for focal epilepsy as monotherapy or first-line adjunctive therapy. 4 While pregabalin shows efficacy as add-on treatment for drug-resistant focal epilepsy (RR 1.95 for 50% seizure reduction), it is associated with significant treatment withdrawal rates (RR 2.60 for withdrawal due to adverse effects). 4

Consider Optimizing Your Current Regimen First

• Verify levetiracetam dosing is optimized before adding a third agent—therapeutic doses range from 1000-3000 mg daily, with each 1000 mg increase raising response odds by 40%. 5

• Check serum levetiracetam levels to assess compliance and adequate dosing before escalating therapy. 1, 6

• Evaluate whether pregabalin is truly necessary in your regimen, as it may contribute more to adverse effects (ataxia, dizziness, somnolence, weight gain) than seizure control. 4

Alternative Third-Line Options

If lacosamide is unavailable or contraindicated, consider these alternatives in order of preference:

Lamotrigine

• Lamotrigine demonstrates particularly effective combinations with levetiracetam and shows superior efficacy to levetiracetam alone in head-to-head trials (HR 1.32 favoring lamotrigine). 7, 2
• Requires slow titration over several weeks to reach therapeutic levels, which delays seizure control. 1
• Avoid combining with valproate unless absolutely necessary, as valproate inhibits lamotrigine metabolism and increases toxicity risk. 3, 2

Valproate

• Valproate remains effective with 88% seizure control rates and combines well with levetiracetam without significant pharmacokinetic interactions. 8, 2
• Absolutely contraindicated in women of childbearing potential due to teratogenicity and neurodevelopmental risks. 1, 9
• Monitor liver function tests regularly due to hepatotoxicity risk. 2

Critical Pitfalls to Avoid

• Do not add enzyme-inducing anticonvulsants (phenytoin, carbamazepine, phenobarbital) as these cause extensive drug interactions, particularly with steroids and other medications. 1, 9

• Avoid combining multiple sodium channel blockers (carbamazepine with lamotrigine or lacosamide) as this increases toxicity without improving efficacy. 2

• Do not skip directly to anesthetic agents (midazolam, propofol, pentobarbital) without trying appropriate second-line oral anticonvulsants first. 8

Monitoring Strategy

• Question about seizure occurrences at each follow-up visit to assess treatment efficacy. 1

• Obtain serum drug levels to explore failure to control epileptic activity and assess compliance. 1, 6

• Consider EEG monitoring if clinical presentation suggests possible non-convulsive status epilepticus or subclinical seizure activity. 8

• Search for precipitating factors including sleep deprivation, alcohol use, medication non-compliance, and intercurrent illness that can trigger breakthrough seizures. 8